Skip to search formSkip to main contentSkip to account menu

Stage II Nasopharyngeal Carcinoma

Known as: Stage II Nasopharyngeal Carcinoma AJCC v7 
Stage II includes: (T1, N1, M0); (T2, N0, M0); (T2, N1, M0). T1: Nasopharyngeal cancer with tumor confined to the nasopharynx, or tumor extending to… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Abstract Purpose To investigate the follow-up strategy of stage II NPC based on event dynamics. Methods Stage II NPC patients… 
2019
2019
Objective: To facilitate decision-making support for individual patients, development and external validation of a nomogram was… 
2018
2018
In this study, we examined whether combining neoadjuvant chemotherapy (NAC) and/or concurrent chemotherapy (CC) with intensity… 
2016
2016
Objective This study aimed to explore whether concurrent chemoradiotherapy (CCRT) with or without Adjuvant Chemotherapy (AC… 
2015
2015
Purpose To define the role of neoadjuvant and concurrent chemotherapy in stage II nasopharyngeal carcinoma, we compared the… 
2014
2014
Abstract Purpose: To define the role of chemotherapy (CT) in stage II nasopharyngeal cancer (NPC), we analyzed the treatment… 
2007
2007
6036 Background: Xerostomia is ubiquitous after conventional radiotherapy (CRT) for nasopharyngeal carcinoma (NPC). Intensity… 
2005
2005
Introduction: Stage II nasopharyngeal carcinoma (NPC) treated with conventionally fractionated radiotherapy results in loco…